What if BWS newborn low blood sugar won't stabilize?

When a newborn’s blood sugar remains dangerously low despite extra feedings or high-glucose IV fluids, it is often due to hyperinsulinism—a condition where the pancreas produces too much insulin. In Beckwith-Wiedemann syndrome (BWS), while many newborns experience mild low blood sugar that resolves quickly, some develop severe, persistent hyperinsulinism that requires specialized medical intervention ^[1][2].

According to the 2018 international consensus guidelines for BWS, there is a clear, step-by-step treatment hierarchy designed to stabilize your baby’s blood sugar and protect their developing brain ^[2]. Keep in mind that for most BWS babies, even severe hyperinsulinism eventually resolves on its own over months or a few years, though the exact timeline varies.

The Treatment Hierarchy for Persistent Hyperinsulinism

If standard IV fluids are not enough to keep blood sugar levels safe, your baby’s care team will move through a specific sequence of treatments. During this time, they may use a temporary IV medication called glucagon as a bridge to keep blood sugar stable while deciding on long-term medications.

1. First-Line Medical Therapy: Diazoxide

The first long-term medication doctors usually try is diazoxide ^[3]. This oral medication works by telling the pancreas to stop releasing so much insulin ^[3]. For many babies with BWS, this is enough to safely regulate their blood sugar. However, its effectiveness can depend on the specific genetic cause of your child’s BWS ^[3][4].

If diazoxide works, your baby may need to take it for several months. Keep in mind that it can take 3 to 5 days for the medication to reach its full effect, so you may not see an immediate fix. While generally safe, doctors will monitor your baby for side effects, such as fluid retention or, in rare cases, pulmonary hypertension ^[5]. Additionally, diazoxide almost always causes hypertrichosis (temporary excessive growth of body and facial hair). While this can be surprising and distressing to see on your newborn, it is entirely harmless and goes away completely once the medication is stopped.

2. Transitioning to Continuous Feeds or Octreotide

If your baby is unresponsive to diazoxide, the medical team will move to second-line therapies ^[6][7].

• Continuous Enteral Feeds: Sometimes, providing a steady, uninterrupted supply of breastmilk or formula through a feeding tube directly into the stomach can keep blood sugar stable.
• Octreotide: This is an injectable medication that strongly blocks the release of insulin ^[7]. While effective, octreotide is used with caution in newborns because it can reduce blood flow to the gut, carrying a risk of a serious intestinal condition called necrotizing enterocolitis (NEC) ^[7][8]. The medical team will weigh this risk carefully and monitor your baby’s digestion very closely—such as checking their tummy and stools—to catch any signs of trouble early.

3. Genetic Testing for KATP Channel Mutations

If the hypoglycemia is severe and resistant to medication, your doctor will likely recommend specific genetic testing looking for mutations in the KATP channel genes (ABCC8 and KCNJ11) ^[9]. These genes control how insulin is released. Testing for these mutations helps doctors understand exactly why the medications aren’t working and whether the excessive insulin is coming from the entire pancreas (diffuse) or just one specific, hyperactive spot (focal) ^[9][10]. This information is critical for planning the next steps in treatment.

4. Surgical Intervention: Partial Pancreatectomy

In very rare, severe cases where persistent hyperinsulinism simply does not respond to any medical therapy, surgery may be considered ^[11][12]. This procedure, called a partial pancreatectomy, involves removing the portion of the pancreas that is overproducing insulin ^[11][1].

Before surgery, doctors will use specialized imaging, usually an 18F-DOPA PET scan, to find the exact location of the problem ^[13][14]. If the scan and genetic testing show a “focal” spot of overactivity, surgeons can remove just that small area ^[15][13]. If the entire pancreas is involved, a larger portion may need to be removed ^[15]. Because surgery carries long-term risks, including the potential development of diabetes later in life, it is strictly reserved as a last resort when medications fail ^[16][17].

Every step in this process is closely monitored by a team of specialists, usually including a pediatric endocrinologist (hormone specialist) and a neonatologist. They will closely monitor your baby’s blood sugar levels—using frequent heel pricks or continuous glucose monitors—and will work with you to find the safest, most effective way to keep your baby’s blood sugar stable.